DD130855A5 - Verfahren zur herstellung von neuen hydroxyhexyhydrobenzo-eckige klammer auf beta eckige klammer zu chinolin und deren zwischenprodukte - Google Patents

Verfahren zur herstellung von neuen hydroxyhexyhydrobenzo-eckige klammer auf beta eckige klammer zu chinolin und deren zwischenprodukte

Info

Publication number
DD130855A5
DD130855A5 DD7700198919A DD19891977A DD130855A5 DD 130855 A5 DD130855 A5 DD 130855A5 DD 7700198919 A DD7700198919 A DD 7700198919A DD 19891977 A DD19891977 A DD 19891977A DD 130855 A5 DD130855 A5 DD 130855A5
Authority
DD
German Democratic Republic
Prior art keywords
square
hydroxyhexyhydrobenzo
chinolin
beta
intermediate products
Prior art date
Application number
DD7700198919A
Other languages
German (de)
English (en)
Inventor
Michael R Johnson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD130855A5 publication Critical patent/DD130855A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C07C43/1782—Unsaturated ethers containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/205—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring
    • C07C43/2055—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring containing more than one ether bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5456—Arylalkanephosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DD7700198919A 1976-05-17 1977-05-13 Verfahren zur herstellung von neuen hydroxyhexyhydrobenzo-eckige klammer auf beta eckige klammer zu chinolin und deren zwischenprodukte DD130855A5 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68733276A 1976-05-17 1976-05-17
US75361976A 1976-12-22 1976-12-22
US77792877A 1977-03-15 1977-03-15

Publications (1)

Publication Number Publication Date
DD130855A5 true DD130855A5 (de) 1978-05-10

Family

ID=27418484

Family Applications (1)

Application Number Title Priority Date Filing Date
DD7700198919A DD130855A5 (de) 1976-05-17 1977-05-13 Verfahren zur herstellung von neuen hydroxyhexyhydrobenzo-eckige klammer auf beta eckige klammer zu chinolin und deren zwischenprodukte

Country Status (23)

Country Link
JP (1) JPS6016426B2 (enExample)
AR (1) AR215896A1 (enExample)
BG (4) BG27897A3 (enExample)
CA (1) CA1095909A (enExample)
CH (2) CH626881A5 (enExample)
DD (1) DD130855A5 (enExample)
DE (1) DE2722383A1 (enExample)
DK (1) DK212677A (enExample)
ES (4) ES458812A1 (enExample)
FI (1) FI64141C (enExample)
FR (2) FR2362129A1 (enExample)
GR (1) GR74122B (enExample)
IL (1) IL52087A (enExample)
LU (1) LU77341A1 (enExample)
NL (2) NL170141C (enExample)
NO (1) NO147028C (enExample)
NZ (1) NZ184114A (enExample)
PH (1) PH16833A (enExample)
PT (1) PT66550B (enExample)
RO (1) RO76839A (enExample)
SE (1) SE7704749L (enExample)
SU (1) SU1098520A3 (enExample)
YU (2) YU156982A (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2802211A1 (de) * 1978-01-19 1979-07-26 Basf Ag N-substituierte 2,6-dialkylaniline und verfahren zur herstellung von n- substituierten 2,6-dialkylanilinen
US4206225A (en) * 1978-09-22 1980-06-03 Pfizer Inc. 2,10-Disubstituted dibenzo[b,d]pyrans and benzo[c]quinolines
US4228169A (en) * 1979-06-26 1980-10-14 Pfizer Inc. 1,9-Dihydroxyoctahydrobenzo[c]quinolines and 1-hydroxyhexahydrobenzo[c]quinoline-9(8H)-ones as antiemetic agents
US4309545A (en) * 1980-07-28 1982-01-05 Pfizer Inc. Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof
US4406888A (en) * 1981-01-09 1983-09-27 Pfizer Inc. Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution
HU194858B (en) * 1982-12-03 1988-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them
CN105924386A (zh) * 2009-03-25 2016-09-07 Abbvie 公司 抗病毒化合物和其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
US3649650A (en) * 1970-02-13 1972-03-14 Little Inc A Novel derivatives of tetrahydro-cannabinol
CA994791A (en) * 1971-05-12 1976-08-10 Louis S. Harris Esters of benzopyrans
US3856821A (en) * 1973-07-18 1974-12-24 Smithkline Corp ALKOXY DIBENZO (b,d) PYRANS
US3968125A (en) * 1973-11-05 1976-07-06 Eli Lilly And Company Dihydroxyhexahydrodibenzo[b,d]pyrans
US3928598A (en) * 1973-11-05 1975-12-23 Lilly Co Eli Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug
US3944673A (en) * 1973-11-05 1976-03-16 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as analgesic drugs
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor

Also Published As

Publication number Publication date
BG28415A4 (bg) 1980-04-15
AU2516277A (en) 1978-06-22
NL7705433A (nl) 1977-11-21
PH16833A (en) 1984-03-06
ES458812A1 (es) 1978-08-16
NL170141C (nl) 1982-10-01
FR2362129A1 (fr) 1978-03-17
CA1095909A (en) 1981-02-17
NO147028B (no) 1982-10-11
NO771738L (no) 1977-11-18
FI771550A7 (enExample) 1977-11-18
SE7704749L (sv) 1977-12-05
LU77341A1 (enExample) 1977-12-13
YU156882A (en) 1983-02-28
ES469203A1 (es) 1978-11-16
PT66550B (en) 1978-10-18
PT66550A (en) 1977-06-01
JPS6016426B2 (ja) 1985-04-25
SU1098520A3 (ru) 1984-06-15
FI64141C (fi) 1983-10-10
NZ184114A (en) 1982-02-23
BG27897A3 (bg) 1980-01-15
RO76839A (ro) 1981-05-30
IL52087A0 (en) 1977-07-31
BG28414A4 (bg) 1980-04-15
YU156982A (en) 1983-02-28
AR215896A1 (es) 1979-11-15
BG28416A4 (en) 1980-04-15
JPS52144672A (en) 1977-12-02
FI64141B (fi) 1983-06-30
DK212677A (da) 1977-11-18
FR2446284B1 (enExample) 1983-08-26
CH628034A5 (en) 1982-02-15
FR2362129B1 (enExample) 1983-05-20
GR74122B (enExample) 1984-06-06
DE2722383C2 (enExample) 1990-06-07
IL52087A (en) 1981-11-30
ES469204A1 (es) 1978-11-16
FR2446284A1 (fr) 1980-08-08
NO147028C (no) 1983-01-19
DE2722383A1 (de) 1977-12-01
CH626881A5 (en) 1981-12-15
NL7804461A (nl) 1978-08-31
ES469202A1 (es) 1978-11-16

Similar Documents

Publication Publication Date Title
ATE86987T1 (de) Ausgangsprodukte fuer 7-acylamino-3vinylcephalosporans|ure-derivate und verfahren zu deren herstellung.
AT342808B (de) Feuerabschirmende glasscheibe und verfahren zu deren herstellung
LU79350A1 (de) Cephemderivate und verfahren zu ihrer herstellung
AT361459B (de) Verfahren zur herstellung von neuen stilben- derivaten und deren salzen
DE3072196D1 (de) Verformbare metall-kunststoff-metall-schichtstoffe und verfahren zu deren herstellung.
ATE6342T1 (de) Wasser-in-oel-emulsionen und verfahren zu deren herstellung.
DD131648A5 (de) Verfahren zur herstellung von 6a,10a-trans-1-hydroxy-3-substituierten-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9h-dibenzo eckige klammer auf b,d eckige klammer zu-pyran-9-onen
DE3855052D1 (de) Verbundmaterial auf Magnesiumbasis und Verfahren zu seiner Herstellung
DD135490A5 (de) Verfahren zur herstellung von neuen 5,11-dihydro-6h-pyrido eckige klammer auf 2,3-b eckige klammer zu eckige klammer auf 1,4 eckige klammer zu benzodiazepin-6-onen
DD135496A5 (de) Verfahren zur herstellung von zwischenprodukten fuer aminoglycoside antibiotica
AT374672B (de) Spannbettuch und verfahren zu seiner herstellung
ATA709574A (de) Registriermetallpapier und verfahren zu dessen herstellung
LU80083A1 (de) Antithrombotische arzneimittelkombination und verfahren zu ihrer herstellung
AT360719B (de) Asbestfreie bauplatten-rohplatte auf zement- basis und verfahren zu deren herstellung
LU79124A1 (de) Neue arzneimittelkombinationen und verfahren zu ihrer herstellung
DD137933A5 (de) Verfahren zur herstellung von neuen imidazo-isochinolin-dionen
LU79589A1 (de) Roh-und fuellmasse fuer nahrungs-und genussmittel und verfahren zu deren herstellung
DD131028A5 (de) Verfahren zur herstellung von pregnan-derivaten
AT384427B (de) Verfahren zur herstellung von neuen tricyclischen imidazolderivaten und ihrer pharmazeutisch verwendbaren salzen
ATA751878A (de) Flaechige strickware und verfahren zu deren herstellung
AT352102B (de) Verfahren zur herstellung von neuen diisocyanaten
AT367792B (de) Stueckseife und verfahren zu deren herstellung
PT67707A (de) Triazolo-thieno-diazepin-1-one verfahren zu ihrer herstellung und arzneimittel
DD131469A5 (de) Verfahren zur herstellung von dl-6a,10a-cis-1-hydroxy-3-substituierter-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9h-dibenzo eckige klammer auf b,d eckige klammer zu pyran-9-onen
PT64922A (de) Azabicycloalkane und verfahren zu ihrer herstellung